World's Best Scientists 2026 revealed!

D-Index & Metrics

Molecular Biology

D-Index
46
Citations
25621
World Ranking
2766
National Ranking
205

Fumie Hosoda publication distribution in Molecular Biology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Molecular Biology in 2026. The highlighted bar marks where Fumie Hosoda sits on this spectrum.

47–56 publications: 7 scientists 57–66 publications: 17 scientists 67–76 publications: 65 scientists 77–86 publications: 90 scientists 87–96 publications: 125 scientists 97–106 publications: 131 scientists 107–116 publications: 162 scientists 117–126 publications: 177 scientists 127–136 publications: 158 scientists 137–146 publications: 158 scientists 147–156 publications: 146 scientists 157–166 publications: 159 scientists 167–176 publications: 131 scientists 177–186 publications: 110 scientists 187–196 publications: 112 scientists 197–206 publications: 100 scientists 207–216 publications: 89 scientists 217–226 publications: 98 scientists 227–236 publications: 74 scientists 237–246 publications: 72 scientists 247–256 publications: 63 scientists 257–266 publications: 53 scientists 267–276 publications: 54 scientists 277–286 publications: 49 scientists 287–296 publications: 52 scientists 297–306 publications: 43 scientists 307–316 publications: 46 scientists 317–326 publications: 41 scientists 327–336 publications: 42 scientists 337–346 publications: 31 scientists 347–356 publications: 28 scientists 357–366 publications: 29 scientists 367–376 publications: 26 scientists 377–386 publications: 24 scientists 387–396 publications: 24 scientists 397–406 publications: 14 scientists 407–416 publications: 13 scientists 417–426 publications: 20 scientists 427–436 publications: 12 scientists 437–446 publications: 20 scientists 447–456 publications: 11 scientists 457–466 publications: 10 scientists 467–476 publications: 14 scientists 477–486 publications: 14 scientists 487–496 publications: 10 scientists 497–506 publications: 13 scientists 507–516 publications: 13 scientists 517–526 publications: 2 scientists 527–536 publications: 4 scientists 537–546 publications: 6 scientists 547–556 publications: 8 scientists 557–563 publications: 6 scientists 564+ publications: 100 scientists
47 publications 564+

This scientist: 89 publications — 7th percentile

7% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 564 publications or more.

Fumie Hosoda D-index placement in Molecular Biology in 2026

The chart shows the D-index (discipline H-index) distribution of Molecular Biology scientists ranked by Research.com in 2026. The highlighted bar marks where Fumie Hosoda sits on this spectrum.

40–41 D-Index: 36 scientists 42–43 D-Index: 101 scientists 44–45 D-Index: 115 scientists 46–47 D-Index: 121 scientists 48–49 D-Index: 118 scientists 50–51 D-Index: 130 scientists 52–53 D-Index: 106 scientists 54–55 D-Index: 116 scientists 56–57 D-Index: 113 scientists 58–59 D-Index: 129 scientists 60–61 D-Index: 120 scientists 62–63 D-Index: 105 scientists 64–65 D-Index: 131 scientists 66–67 D-Index: 95 scientists 68–69 D-Index: 97 scientists 70–71 D-Index: 106 scientists 72–73 D-Index: 83 scientists 74–75 D-Index: 89 scientists 76–77 D-Index: 77 scientists 78–79 D-Index: 70 scientists 80–81 D-Index: 73 scientists 82–83 D-Index: 60 scientists 84–85 D-Index: 48 scientists 86–87 D-Index: 45 scientists 88–89 D-Index: 50 scientists 90–91 D-Index: 31 scientists 92–93 D-Index: 51 scientists 94–95 D-Index: 43 scientists 96–97 D-Index: 38 scientists 98–99 D-Index: 39 scientists 100–101 D-Index: 41 scientists 102–103 D-Index: 29 scientists 104–105 D-Index: 33 scientists 106–107 D-Index: 35 scientists 108–109 D-Index: 20 scientists 110–111 D-Index: 38 scientists 112–113 D-Index: 19 scientists 114–115 D-Index: 28 scientists 116–117 D-Index: 13 scientists 118–119 D-Index: 23 scientists 120–121 D-Index: 16 scientists 122–123 D-Index: 15 scientists 124–125 D-Index: 11 scientists 126–127 D-Index: 21 scientists 128–129 D-Index: 7 scientists 130–131 D-Index: 13 scientists 132–133 D-Index: 14 scientists 134–135 D-Index: 17 scientists 136–137 D-Index: 9 scientists 138–139 D-Index: 8 scientists 140–141 D-Index: 16 scientists 142–143 D-Index: 7 scientists 144 D-Index: 7 scientists 145+ D-Index: 100 scientists
40 D-Index 145+

This scientist: 46 D-Index — 10th percentile

10% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 145 D-Index or more.

Overview

Fumie Hosoda is affiliated with the National Cancer Centre in Japan and has contributed to multiple research areas within medicine and biochemistry, genetics, and molecular biology. Their work primarily focuses on oncology, cancer research, and related subfields, including molecular biology, surgery, and pulmonary and respiratory medicine.

The scientist's research includes significant topics such as RNA modifications and cancer, cancer-related gene regulation, cancer-related molecular mechanisms, genetic factors in colorectal cancer, cancer genomics and diagnostics, cholangiocarcinoma and gallbladder cancer studies, as well as lung cancer treatments and mutations.

Key recent publications authored or co-authored by Fumie Hosoda include:

  • Multiancestry genomic and transcriptomic analysis of gastric cancer, 2023, Nature Genetics
  • Oncogenic structural aberration landscape in gastric cancer genomes, 2023, Nature Communications
  • Pharmacokinetic and pharmacogenomic analysis of low-dose afatinib treatment in elderly patients with EGFR mutation-positive non-small cell lung cancer, 2021, European Journal of Cancer
  • Genomic and Pathologic Profiling of Very Well-Differentiated Gastric Adenocarcinoma of Intestinal Type, 2024, The American Journal of Surgical Pathology
  • Comprehensive biomarker analysis from phase II study of nivolumab in patients with thymic carcinoma, 2023, Frontiers in Oncology

Frequent collaborators in research include:

  • Hiromi Nakamura
  • Tatsuhiro Shibata
  • Yasushi Totoki
  • Hirofumi Rokutan
  • Natsuko Hama

Fumie Hosoda has published in a range of journals, with frequent appearances in:

  • Nature Genetics
  • Nature Communications
  • European Journal of Cancer
  • The American Journal of Surgical Pathology
  • Frontiers in Oncology

Best Publications

  • Signatures of mutational processes in human cancer

    Ludmil B. Alexandrov;Serena Nik-Zainal;Serena Nik-Zainal;David C. Wedge;Samuel A. J. R. Aparicio

  • Pan-cancer analysis of whole genomes

    Peter J. Campbell;Gad Getz;Jan O. Korbel;Joshua M. Stuart

  • Metagenomic and metabolomic analyses reveal distinct stage-specific phenotypes of the gut microbiota in colorectal cancer

    Shinichi Yachida;Sayaka Mizutani;Hirotsugu Shiroma;Satoshi Shiba

  • Genomic spectra of biliary tract cancer

    Hiromi Nakamura;Yasuhito Arai;Yasushi Totoki;Tomoki Shirota

  • Whole-genome sequencing of liver cancers identifies etiological influences on mutation patterns and recurrent mutations in chromatin regulators

    Akihiro Fujimoto;Yasushi Totoki;Tetsuo Abe;Keith A. Boroevich

  • Patterns of somatic structural variation in human cancer genomes

    Yilong Li;Nicola D Roberts;Jeremiah A Wala;Jeremiah A Wala;Ofer Shapira;Ofer Shapira

  • Trans-ancestry mutational landscape of hepatocellular carcinoma genomes

    Yasushi Totoki;Kenji Tatsuno;Kyle R. Covington;Hiroki Ueda

  • Whole-genome mutational landscape and characterization of noncoding and structural mutations in liver cancer

    Akihiro Fujimoto;Mayuko Furuta;Yasushi Totoki;Tatsuhiko Tsunoda

  • Fibroblast growth factor receptor 2 tyrosine kinase fusions define a unique molecular subtype of cholangiocarcinoma

    Yasuhito Arai;Yasushi Totoki;Fumie Hosoda;Tomoki Shirota

  • High-resolution characterization of a hepatocellular carcinoma genome

    Yasushi Totoki;Kenji Tatsuno;Shogo Yamamoto;Yasuhito Arai

  • The Partner Gene of AML1 in t(16;21) Myeloid Malignancies Is a Novel Member of the MTG8(ETO) Family

    Toshie Gamou;Eiko Kitamura;Fumie Hosoda;Kimiko Shimizu

  • The inv(11)(p15q22) Chromosome Translocation of De Novo and Therapy-Related Myeloid Malignancies Results in Fusion of the Nucleoporin Gene, NUP98, With the Putative RNA Helicase Gene, DDX10

    Yasuhito Arai;Fumie Hosoda;Hirofumi Kobayashi;Kyoko Arai

  • Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation

    I Kitabayashi;Y Aikawa;A Yokoyama;F Hosoda

  • Genome-wide array-based comparative genomic hybridization analysis of pancreatic adenocarcinoma: Identification of genetic indicators that predict patient outcome

    Panayiotis Loukopoulos;Tatsuhiro Shibata;Hiroto Katoh;Akiko Kokubu

  • Genomic Sequencing Identifies ELF3 as a Driver of Ampullary Carcinoma.

    Shinichi Yachida;Laura D. Wood;Masami Suzuki;Erina Takai

  • A BAC-based STS-content map spanning a 35-Mb region of human chromosome 1p35-p36

    Ying Zhang Chen;Yasuhide Hayashi;Jian Guo Wu;Ei ichiro Takaoka

  • A 2-Mb sequence-ready contig map and a novel immunoglobulin superfamily gene IGSF4 in the LOH region of chromosome 11q23.2.

    Hiroki Gomyo;Yasuhito Arai;Akira Tanigami;Yoshinori Murakami

  • Frequent Silencing of the Candidate Tumor Suppressor PCDH20 by Epigenetic Mechanism in Non-Small-Cell Lung Cancers

    Issei Imoto;Hiroyuki Izumi;Sana Yokoi;Hiroshi Hosoda

  • Regulatory Nexus of Synthesis and Degradation Deciphers Cellular Nrf2 Expression Levels

    Takafumi Suzuki;Tatsuhiro Shibata;Kai Takaya;Kouya Shiraishi

  • Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features.

    Tatsuhiro Shibata;Satomi Uryu;Akiko Kokubu;Fumie Hosoda

Frequent Co-Authors

Tatsuhiro Shibata
Tatsuhiro Shibata University of Tokyo
Misao Ohki
Misao Ohki National Cancer Research Institute, UK
Yasuhito Arai
Yasuhito Arai National Cancer Centre
Johji Inazawa
Johji Inazawa Tokyo Medical and Dental University
Yasushi Totoki
Yasushi Totoki National Cancer Centre
Issei Imoto
Issei Imoto University of Tokushima
Setsuo Hirohashi
Setsuo Hirohashi National Cancer Research Institute, UK
Yae Kanai
Yae Kanai Keio University
Tomoo Kosuge
Tomoo Kosuge National Cancer Center
Takuji Okusaka
Takuji Okusaka National Cancer Centre

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Molecular Biology opens doors to diverse career options in research, healthcare, and education. Many students expand their expertise through online programs, which offer flexibility and pathways to advanced roles. For those interested in transitioning to nursing careers, direct entry msn online programs cater to non-nurses seeking a fast track to a master’s degree—perfect for science graduates looking for professional change.

If you're already in the nursing field, comparing institutions becomes crucial. Explore detailed comparisons like capella vs chamberlain rn to bsn to choose the right online RN-to-BSN pathway for your goals. Additionally, many professionals seek efficient advancement with rn to bsn to msn online programs, providing an affordable and streamlined approach to graduate nursing credentials.

When considering online education, always look for nonprofit online universities to ensure program credibility, accreditation, and strong student support. These options can help Molecular Biology graduates and professionals find flexible, reputable ways to advance or shift their careers in the biomedical sciences and beyond.

Best Scientists Citing Fumie Hosoda

Trending Scientists

Recently Published Articles